Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?
- PMID: 28361073
- PMCID: PMC5360618
- DOI: 10.21037/atm.2017.01.21
Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
- 
  
  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.Lancet Oncol. 2016 Dec;17(12):1672-1682. doi: 10.1016/S1470-2045(16)30532-0. Epub 2016 Oct 24. Lancet Oncol. 2016. PMID: 27789196 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        